313 related articles for article (PubMed ID: 26001739)
21. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.
Gao WM; Romkes M; Siegfried JM; Luketich JD; Keohavong P
Mol Carcinog; 2006 Nov; 45(11):828-32. PubMed ID: 16865671
[TBL] [Abstract][Full Text] [Related]
22. Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia.
Bănescu C; Trifa AP; Demian S; Benedek Lazar E; Dima D; Duicu C; Dobreanu M
Biomed Res Int; 2014; 2014():213790. PubMed ID: 24955348
[TBL] [Abstract][Full Text] [Related]
23. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562
[TBL] [Abstract][Full Text] [Related]
24. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
[TBL] [Abstract][Full Text] [Related]
25. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients.
Gal TJ; Huang WY; Chen C; Hayes RB; Schwartz SM
Laryngoscope; 2005 Dec; 115(12):2221-31. PubMed ID: 16369171
[TBL] [Abstract][Full Text] [Related]
26. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
27. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study.
Skjelbred CF; Saebø M; Wallin H; Nexø BA; Hagen PC; Lothe IM; Aase S; Johnson E; Hansteen IL; Vogel U; Kure EH
BMC Cancer; 2006 Mar; 6():67. PubMed ID: 16542436
[TBL] [Abstract][Full Text] [Related]
29. Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors.
Hou SM; Ryk C; Kannio A; Angelini S; Fält S; Nyberg F; Husgafvel-Pursiainen K
Environ Mol Mutagen; 2003; 41(1):37-42. PubMed ID: 12552590
[TBL] [Abstract][Full Text] [Related]
30. Are XPD and XPG gene variants related to the mechanism of oral squamous cell carcinoma?
Avci H; Iplik ES; Aydemir L; Acar S; Kiyak E; Unur M; Cakmakoglu B
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):94-99. PubMed ID: 30672443
[TBL] [Abstract][Full Text] [Related]
31. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
32. Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.
Song X; Sturgis EM; Jin L; Wang Z; Wei Q; Li G
Int J Cancer; 2013 Aug; 133(3):695-704. PubMed ID: 23335232
[TBL] [Abstract][Full Text] [Related]
33. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
Kang S; Sun HY; Zhou RM; Wang N; Hu P; Li Y
Asian Pac J Cancer Prev; 2013; 14(2):941-6. PubMed ID: 23621265
[TBL] [Abstract][Full Text] [Related]
34. Association between genetic polymorphisms in XPD and XRCC1 genes and risks of non-small cell lung cancer in East Chinese Han population.
Du Y; He Y; Mei Z; Qian L; Shi J; Jie Z
Clin Respir J; 2016 May; 10(3):311-7. PubMed ID: 25308691
[TBL] [Abstract][Full Text] [Related]
35. Association of XPD (Lys751Gln) and XRCC1 (Arg280His) gene polymorphisms in myelodysplastic syndrome.
Joshi D; Korgaonkar S; Shanmukhaiah C; Vundinti BR
Ann Hematol; 2016 Jan; 95(1):79-85. PubMed ID: 26482462
[TBL] [Abstract][Full Text] [Related]
36. [Association between genetic polymorphisms of DNA repair genes XRCC1, XPD, XRCC3 and the capacity of DNA repair induce by benzene].
Xu J; Yang M; Huang H; Wang Q
Wei Sheng Yan Jiu; 2007 Sep; 36(5):529-32. PubMed ID: 18095557
[TBL] [Abstract][Full Text] [Related]
37. Influence of allelic Variations of hypoxia-related and DNA repair genes on patient outcome and toxicity in head and neck cancer treated with radiotherapy plus cetuximab.
Muñoz C; Caballero M; Hakim S; Verger E; Grau JJ
Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2193-9. PubMed ID: 26245169
[TBL] [Abstract][Full Text] [Related]
38. Impact of Polymorphism in Base Excision Repair and Nucleotide Excision Repair Genes and Risk of Cervical Cancer: A Case-Control Study.
Datkhile KD; Durgawale PP; Patil MN; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1291-1300. PubMed ID: 35485688
[TBL] [Abstract][Full Text] [Related]
39. Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma.
Mahjabeen I; Ali K; Zhou X; Kayani MA
Tumour Biol; 2014 Jun; 35(6):5971-83. PubMed ID: 24622884
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population.
Wang J; Zhao Y; Jiang J; Gajalakshmi V; Kuriki K; Nakamura S; Akasaka S; Ishikawa H; Suzuki S; Nagaya T; Tokudome S
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1517-25. PubMed ID: 20229274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
